High incidence and recurrence of transitional cell carcinoma in Taiwanese patients with end-stage renal disease

Nephrology

Volumn 16, Issue 2, 2011, Pages 225-231

  Wang, Tsung Yang ^a,b   Hu, Chia Jung ^a,b   Kuo, Chin Wei ^a,b   Chen, Yu ^a,b   Lin, Ja Liang ^a,b   Yang, Chih Wei ^a,b   Yen, Tzung Hai ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

end stage renal disease; haematuria; haemodialysis; peritoneal dialysis; transitional cell carcinoma

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PAIN; CANCER RECURRENCE; CHINESE HERB; CHRONIC GLOMERULONEPHRITIS; DEMOGRAPHY; DIABETES MELLITUS; DIALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HYPERTENSIVE NEPHROSCLEROSIS; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROSCLEROSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS; TAIWAN; TREATMENT OUTCOME; UROLOGIC NEOPLASMS;

EID: 79551527317     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01366.x     Document Type: Article

References (42)

1. Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 2009; 20: 1341-50.
2. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-9.
3. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J. Am. Soc. Nephrol. 2003; 14: 197-207.
4. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML,. Urologic cancers in uremic patients. Am. J. Kidney Dis. 1995; 25: 694-700.
5. Satoh S, Tsuchiya N, Habuchi T, Ishiyama T, Seimo K, Kato T,. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis. J. Urol. 2005; 174: 1749-53.
6. Wu CF, Shee JJ, Ho DR, Chen WC, Chen CS,. Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma. J. Urol. 2004; 171: 126-9.
7. Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST,. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J. Urol. 2006; 176: 477-81.
8. Ou JH, Pan CC, Lin JS, et al. Transitional cell carcinoma in dialysis patients. Eur. Urol. 2000; 37: 90-4.
9. Horiuchi K, Uchikoba T, Oka F, et al. Transitional cell carcinoma of the bladder in four patients on maintenance hemodialysis. J. Nippon Med. Sch. 2004; 71: 408-11.
10. Chang CH, Yang CM, Yang AH,. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer 2007; 109: 1487-92.
11. Wang HB, Hsieh HH, Chen YT, Chiang CY, Cheng YT,. The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients. Clin. Transplant. 2002; 16: 410-13.
12. Webster AC, Wong G, Craig JC, Chapman JR,. Managing cancer risk and decision making after kidney transplantation. Am. J. Transplant. 2008; 8: 2185-91.
13. U.S. Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009.
14. Bretan PN, Jr, Busch MP, Hricak H, Williams RD,. Chronic renal failure: a significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Case reports and review of the literature. Cancer 1986; 57: 1871-9.
15. Gonwa TA, Corbett WT, Schey HM, Buckalew VM, Jr,. Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract. Ann. Intern. Med. 1980; 93: 249-52.
16. Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 2000; 342: 1686-92.
17. Chiang HS, Guo HR, Hong CL, Lin SM, Lee EF,. The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br. J. Urol. 1993; 71: 274-8.
18. Chiou HY, Chiou ST, Hsu YH, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001; 153: 411-18.
19. Golabek T, Darewicz B, Borawska M, Markiewicz R, Socha K, Kudelski J,. Lead concentration in the bladder tissue and blood of patients with bladder cancer. Scand. J. Urol. Nephrol. 2009; 43: 467-70.
20. Kellen E, Zeegers MP, Hond ED, Buntinx F,. Blood cadmium may be associated with bladder carcinogenesis: the Belgian case-control study on bladder cancer. Cancer Detect. Prev. 2007; 31: 77-82.
21. Lin JL, Lin-Tan DT, Hsu KH, Yu CC,. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N. Engl. J. Med. 2003; 348: 277-86.
22. Lin JL, Lin-Tan DT, Yen TH, et al. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis. Am. J. Kidney Dis. 2008; 51: 107-15.
23. Lin JL, Lin-Tan DT, Chen KH, et al. Blood lead levels association with 18-month all-cause mortality in patients with chronic peritoneal dialysis. Nephrol. Dial. Transplant. 2010; 25: 1627-33.
24. Hsu CW, Lin JL, Lin-Tan DT, et al. Association of environmental cadmium exposure with inflammation and malnutrition in maintenance haemodialysis patients. Nephrol. Dial. Transplant. 2009; 24: 1282-8.
25. Mostofi FK, Sobin LH, Torloni H, (eds). Histological Typing of Urinary Tumors. Geneva: World Health Organization, 1973.
26. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer Staging Manual. New York: Springer-Verlag, 2002.
27. Yen TH, Lin JL, Lin-Tan DT, Hsu KH,. Cardiothoracic ratio, inflammation, malnutrition, and mortality in diabetes patients on maintenance hemodialysis. Am. J. Med. Sci. 2009; 337: 421-8.
28. Huang C, Chen YM,. Taiwan society of nephrology: Taiwan renal registry-2004 annual data report. Acta Nephrol. 2007; 21: 285-98.
29. Pan CC, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DM,. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am. J. Clin. Pathol. 2010; 133: 788-95.
30. Li CC, Chang TH, Wu WJ, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur. Urol. 2008; 54: 1127-34.
31. Chung SD, Huang KH, Lai MK, et al. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Am. J. Kidney Dis. 2007; 50: 743-53.
32. Cheng L, Zhang S, Davidson DD, et al. Molecular determinants of tumor recurrence in the urinary bladder. Future Oncol. 2009; 5: 843-57.
33. Alexa A, Baderca F, Lighezan R, Izvernariu D,. Myofibroblasts reaction in urothelial carcinomas. Rom. J. Morphol. Embryol. 2009; 50: 639-43.
34. Yen TH, Chen Y, Fu JF, et al. Proliferation of myofibroblasts in the stroma of renal oncocytoma. Cell Prolif. 2010; 43: 287-96.
35. Grollman AP, Shibutani S, Moriya M, et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. USA 2007; 104: 12129-34.
36. Lin-Tan DT, Lin JL, Wang LH, et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J. Am. Soc. Nephrol. 2007; 18: 2385-91.
37. Hsu CW, Lin JL, Lin-Tan DT, et al. High-calcium dialysate: a factor associated with inflammation, malnutrition and mortality in non-diabetic maintenance haemodialysis patients. Nephrology (Carlton) 2010; 15: 313-20.
38. Yen TH, Lin JL, Lin-Tan DT, Hsu CW,. Association between body mass and mortality in maintenance hemodialysis patients. Ther. Apher. Dial. 2010; 14: 400-8.
39. Liang CC, Huang CC, Wang IK, et al. Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis. Ther. Apher. Dial. 2010; 14: 35-42.
40. Taiwan Cancer Registry. Urinary Bladder Cancer: 1987-2007. [Cited 7 May 2010.] Available from URL
41. Tan LB, Chen KT, Guo HR,. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan. BJU Int. 2008; 102: 48-54.
42. Lee SH, Lin JS, Tzai TS, et al. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract. Eur. Urol. 1996; 29: 266-70; discussion 71.